Advent of Highly Efficient Pipeline Drugs Could Help Liver Disease Therapeutics Companies to Gain Considerable Growth, Says TMR
The global liver diseases therapeutics market is fragmented and is characterized by high competitive rivalry. Companies are investing heavily in research and development to stay in the competition. However, sizeable capital investments can only be afforded by the bigger companies, therefore leading to their dominance in the global liver diseases therapeutics market, finds Transparency Market Research (TMR) in a new study. The vendors prefer to offer only some specific treatments and operate in limited segments of the market. To put...
View full press release